Fibralign Analysis
What is Fibralign?
Fibralign is a Stanford-spinout company focused on developing therapeutic biomedical devices to address significant unmet medical needs. Their primary product, BioBridge, is a collagen matrix that has received FDA 510(k) clearance for soft tissue repair and is being studied for treating secondary lymphedema.
Location
32930 Alvarado-Niles Rd, Union City, California 94587, United States
Employees
11-50
Founded
2007
Funding Status
Series A
Product Features & Capabilities
- BioBridge Collagen Matrix
- Nanoweave Technology
Use Cases
Used in soft tissue repair procedures; Studied for treating secondary lymphedema; Supports surgical treatment advancements; Aids in microsurgical treatment evaluations; Provides scaffolding mimicking human tissue structure
Other Considerations
FDA 510(k) cleared for soft tissue repair; CE mark approved, Class III device; Supported by NCI-funded studies; Recognized by UCSF Rosenman Institute as an innovator
See something that needs updating? Suggest edits to this profile.